Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine.
作者信息
Sellaturay Priya, Nasser Shuaib, Islam Sabita, Gurugama Padmalal, Ewan Pamela W
机构信息
Department of Allergy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Department of Oncology, University of Cambridge (formerly of Department of Medicine), Cambridge, UK.
出版信息
Clin Exp Allergy. 2021 Jun;51(6):861-863. doi: 10.1111/cea.13874. Epub 2021 Apr 9.
Abstract
摘要
相似文献
1
Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine.
Clin Exp Allergy. 2021 Jun;51(6):861-863. doi: 10.1111/cea.13874. Epub 2021 Apr 9.
2
Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights.
Interdiscip Sci. 2021 Jun;13(2):344-347. doi: 10.1007/s12539-021-00438-3. Epub 2021 May 22.
3
Adverse reactions to COVID-19 vaccines: A practical approach.
Clin Exp Allergy. 2021 Jun;51(6):770-777. doi: 10.1111/cea.13880. Epub 2021 Apr 14.
4
Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
Br J Anaesth. 2021 Mar;126(3):e106-e108. doi: 10.1016/j.bja.2020.12.020. Epub 2020 Dec 17.
5
Allergy to COVID-19 vaccines: A current update.
Allergol Int. 2021 Jul;70(3):313-318. doi: 10.1016/j.alit.2021.04.003. Epub 2021 Apr 23.
6
Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase.
Pediatr Blood Cancer. 2021 Nov;68(11):e29295. doi: 10.1002/pbc.29295. Epub 2021 Aug 16.
7
Successful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy.
J Korean Med Sci. 2022 Aug 15;37(32):e251. doi: 10.3346/jkms.2022.37.e251.
8
Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine.
Intern Med J. 2022 Oct;52(10):1818-1820. doi: 10.1111/imj.15821. Epub 2022 Oct 6.
9
[Allergy to Pfizer-BioNTech® vaccine demonstrated by skin testing].
Rev Alerg Mex. 2023 Jan 4;69(2):89-92. doi: 10.29262/ram.v69i2.1088.
10
Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2.
引用本文的文献
1
Evaluating vaccination dosing strategies for SARS-CoV-2 in patients at high-risk for allergic reactions: Insights from vaccination campaign.
World Allergy Organ J. 2025 Jul 28;18(8):101095. doi: 10.1016/j.waojou.2025.101095. eCollection 2025 Aug.
2
Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality.
Vaccines (Basel). 2025 Jul 2;13(7):723. doi: 10.3390/vaccines13070723.
3
NMR Assessment of the High Order Structure of Biological Therapeutics in Erythrocytes Provides a Tool for Drug Delivery Design.
J Am Chem Soc. 2025 Jul 30;147(30):26379-26388. doi: 10.1021/jacs.5c05617. Epub 2025 Jul 16.
4
Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study.
Nat Commun. 2025 Jul 15;16(1):6514. doi: 10.1038/s41467-025-61613-4.
5
Eosinophils and COVID-19: Insights into immune complexity and vaccine safety.
Clin Transl Allergy. 2025 Mar;15(3):e70050. doi: 10.1002/clt2.70050.
6
Multilayer Adjuvanted Influenza Protein Nanoparticles Improve Intranasal Delivery and Antigen-Specific Immunity.
ACS Nano. 2025 Feb 25;19(7):7005-7025. doi: 10.1021/acsnano.4c14735. Epub 2025 Feb 15.
7
Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database.
BMC Public Health. 2024 Oct 21;24(1):2905. doi: 10.1186/s12889-024-20297-z.
8
Impact of the Hydrophilicity of Poly(sarcosine) on Poly(ethylene glycol) (PEG) for the Suppression of Anti-PEG Antibody Binding.
ACS Omega. 2024 Jul 12;9(32):34577-34588. doi: 10.1021/acsomega.4c02655. eCollection 2024 Aug 13.
9
Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adults.
Allergy. 2024 Sep;79(9):2502-2523. doi: 10.1111/all.16231. Epub 2024 Jul 20.
10
Recombinant L-asparaginase: PEGylation with Low Molecular Weight Polyethylene Glycol, Molecular Dynamics Simulation, and Serum half-life and Biochemical Characterization.
Curr Pharm Biotechnol. 2025;26(4):617-629. doi: 10.2174/0113892010309260240624072408.
本文引用的文献
1
Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients.
Clin Exp Allergy. 2021 Mar;51(3):463-470. doi: 10.1111/cea.13822. Epub 2021 Jan 15.
2
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437. doi: 10.1016/j.jaip.2020.12.047. Epub 2020 Dec 31.
3
Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
Br J Anaesth. 2021 Mar;126(3):e106-e108. doi: 10.1016/j.bja.2020.12.020. Epub 2020 Dec 17.
4
Covid-19: People with history of significant allergic reactions should not receive Pfizer vaccine, says regulator.
BMJ. 2020 Dec 10;371:m4780. doi: 10.1136/bmj.m4780.
5
Nanomedicine and the COVID-19 vaccines.
Nat Nanotechnol. 2020 Dec;15(12):963. doi: 10.1038/s41565-020-00820-0.
6
Polyethylene Glycol-Induced Systemic Allergic Reactions (Anaphylaxis).
J Allergy Clin Immunol Pract. 2021 Feb;9(2):670-675. doi: 10.1016/j.jaip.2020.09.029. Epub 2020 Oct 1.
7
Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016.
J Allergy Clin Immunol. 2019 Apr;143(4):1465-1473. doi: 10.1016/j.jaci.2018.12.1003. Epub 2019 Jan 14.
8
Diagnostic Value of Tryptase in Food Allergic Reactions: A Prospective Study of 160 Adult Peanut Challenges.
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1692-1698.e1. doi: 10.1016/j.jaip.2018.01.006. Epub 2018 Mar 1.
9
Immediate-type hypersensitivity to polyethylene glycols: a review.
Clin Exp Allergy. 2016 Jul;46(7):907-22. doi: 10.1111/cea.12760.
Zotero 插件